PIM1 phosphorylates ABI2 to enhance actin dynamics and promote tumor invasion
Journal of Cell Biology · 2023
DOI: 10.1083/jcb.202208136 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cell Biology, 2023. Verfasst von Corbin C Jensen und 15 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Biology Graduate Program, University of Arizona , Tucson, AZ, USA. Hauptthemen laut MEDLINE: Actins, Adaptor Proteins, Signal Transducing, Proto-Oncogene Proteins c-pim-1, Prostatic Neoplasms. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Distinguishing key factors that drive the switch from indolent to invasive disease will make a significant impact on guiding the treatment of prostate cancer (PCa) patients. Here, we identify a novel signaling pathway linking hypoxia and PIM1 kinase to the actin cytoskeleton and cell motility. An unbiased proteomic screen identified Abl-interactor 2 (ABI2), an integral member of the wave regulatory complex (WRC), as a PIM1 substrate. Phosphorylation of ABI2 at Ser183 by PIM1 increased ABI2 protein levels and enhanced WRC formation, resulting in increased protrusive activity and cell motility. Cell protrusion induced by hypoxia and/or PIM1 was dependent on ABI2. In vivo smooth muscle invasion assays showed that overexpression of PIM1 significantly increased the depth of tumor cell invasion, and treatment with PIM inhibitors significantly reduced intramuscular PCa invasion. This research uncovers a HIF-1-independent signaling axis that is critical for hypoxia-induced invasion and establishes a novel role for PIM1 as a key regulator of the actin cytoskeleton.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cancer Biology Graduate Program, University of Arizona , Tucson, AZ, USA.
- Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, SC, USA.
- Department of Medicine, University of Arizona, Tucson, AZ, USA.
- University of Arizona Cancer Center , Tucson, AZ, USA.
- Department of Cellular and Molecular Medicine, University of Arizona, Tucson, AZ, USA.
ORCID-Profile: Corbin C Jensen, Amber N Clements, Hope Liou, Lauren E Ball, Jennifer R Bethard, Paul R Langlais, Rachel K Toth, Shailender S Chauhan, Andrea L Casillas, Sohail R Daulat, Andrew S Kraft, Anne E Cress, Cindy K Miranti, Ghassan Mouneimne, Greg C Rogers, Noel A Warfel
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
- NIH HHS
- U.S. Department of Defense
- National Cancer Institute
- National Institutes of Health
- University of Arizona
Zitieren
APA
Jensen, C. C., Clements, A. N., Liou, H., Ball, L. E., Bethard, J. R., Langlais, P. R., Toth, R. K., Chauhan, S. S., Casillas, A. L., Daulat, S. R., Kraft, A. S., Cress, A. E., Miranti, C. K., Mouneimne, G., Rogers, G. C., & Warfel, N. A. (2023). PIM1 phosphorylates ABI2 to enhance actin dynamics and promote tumor invasion. Journal of Cell Biology. https://doi.org/10.1083/jcb.202208136
Vancouver
Jensen CC, Clements AN, Liou H, Ball LE, Bethard JR, Langlais PR, et al. PIM1 phosphorylates ABI2 to enhance actin dynamics and promote tumor invasion. Journal of Cell Biology. 2023. doi:10.1083/jcb.202208136
BibTeX
@article{Jensen2023,
author = {Jensen, Corbin C and Clements, Amber N and Liou, Hope and Ball, Lauren E and Bethard, Jennifer R and Langlais, Paul R and Toth, Rachel K and Chauhan, Shailender S and Casillas, Andrea L and Daulat, Sohail R and Kraft, Andrew S and Cress, Anne E and Miranti, Cindy K and Mouneimne, Ghassan and Rogers, Greg C and Warfel, Noel A},
title = {PIM1 phosphorylates ABI2 to enhance actin dynamics and promote tumor invasion},
journal = {Journal of Cell Biology},
year = {2023},
doi = {10.1083/jcb.202208136}
}
EUVIMED